About
Jacobiopharma is a China-based biopharmaceutical company focused on developing first-in-class novel drugs targeting validated but difficult-to-drug oncogenic signaling pathways for cancer treatment.
Explore Jacobiopharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.